Premier Health of America Inc (TSE:PHA)
:PHA
Top Page
Premier Health of America Inc
(PHA)
Select Model
Select Model
Rating:46Neutral
Price Target:
C$0.03
▲(25.00% Upside)
Action:ReiteratedDate:02/27/26
The score is primarily held down by weak financial performance—ongoing losses, declining revenue, and a stressed balance sheet with negative equity—despite improved recent cash flow. Technicals are mixed but skew weak relative to longer-term averages, and valuation support is limited due to negative earnings and no dividend data.
Positive Factors
Improved cash generation
Trailing-twelve-month operating and free cash flow moved positive and improved year-over-year, indicating better cash discipline. Sustained positive FCF can fund operations, reduce near-term external financing needs and provide a bridge while management executes margin or revenue fixes.
Negative Factors
Negative equity and high leverage
Negative shareholders' equity signals an impaired capital base and greater insolvency risk; combined with high relative debt the company faces constrained financial flexibility. This elevates refinancing, covenant, and dilution risk and limits strategic optionality over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved cash generation
Trailing-twelve-month operating and free cash flow moved positive and improved year-over-year, indicating better cash discipline. Sustained positive FCF can fund operations, reduce near-term external financing needs and provide a bridge while management executes margin or revenue fixes.
Read all positive factors
Premier Health of America Inc (PHA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$1.11M
Dividend YieldN/A
Average Volume (3M)33.75K
Price to Earnings (P/E)―
Beta (1Y)0.50
Revenue Growth-22.61%
EPS Growth7.72%
CountryCA
Employees589
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.05
Shares Outstanding55,514,153
10 Day Avg. Volume13,466
30 Day Avg. Volume33,746
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.15
Price to Sales (P/S)0.02
P/FCF Ratio0.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$157.17M
Premier Health of America Inc Business Overview & Revenue Model
Company Description
Premier Health of America Inc., a specialized healthcare services company, provides staffing and outsourced service solutions for healthcare needs in Canada. It also offers health consulting, nursing, and health-care services in remote communities...
How the Company Makes Money
null...
Premier Health of America Inc Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
18
Very Negative
Cash Flow
58
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 87.67M | 101.97M | 158.19M | 90.39M | 80.51M | 66.63M |
| Gross Profit | 4.73M | 8.40M | 27.89M | 23.34M | 20.08M | 16.25M |
| EBITDA | -4.32M | -3.67M | 384.00K | 5.87M | 5.61M | 5.90M |
| Net Income | -15.73M | -15.44M | -12.49M | -1.70M | -111.51K | 1.50M |
Balance Sheet | ||||||
| Total Assets | 42.63M | 47.22M | 73.72M | 56.71M | 57.09M | 39.13M |
| Cash, Cash Equivalents and Short-Term Investments | 92.00K | 1.40M | 1.50M | 1.15M | 5.12M | 2.68M |
| Total Debt | 45.34M | 45.34M | 49.85M | 27.27M | 22.84M | 12.30M |
| Total Liabilities | 56.43M | 58.49M | 69.64M | 40.27M | 38.62M | 21.81M |
| Stockholders Equity | -13.80M | -11.27M | 4.08M | 16.44M | 18.47M | 17.32M |
Cash Flow | ||||||
| Free Cash Flow | 13.71M | 12.33M | 3.02M | -3.20M | 3.38M | 24.13K |
| Operating Cash Flow | 14.78M | 12.45M | 5.93M | -1.27M | 4.04M | 1.97M |
| Investing Cash Flow | -1.91M | -2.53M | -26.43M | -3.33M | -12.67M | -16.08M |
| Financing Cash Flow | -12.82M | -10.02M | 20.85M | 625.00K | 11.07M | 15.56M |
Premier Health of America Inc Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.02
Negative
0.03
Negative
Market Momentum
>-0.01
Negative
47.97
Neutral
0.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PHA, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.97 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:PHA.
Premier Health of America Inc Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | C$291.07M | 10.68 | 89.16% | 2.35% | -40.05% | 558.77% | |
66 Neutral | C$225.99M | 9.17 | 28.24% | 1.03% | 0.19% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | C$1.11M | -0.14 | 202.02% | ― | -22.61% | 7.72% | |
44 Neutral | C$13.86M | -5.16 | ― | ― | ― | ― |
* Healthcare Sector Average
TSE:PHA
Premier Health of America Inc
0.02
-0.04
-66.67%
TSE:CRRX
CareRx
3.60
1.04
40.54%
TSE:NUMI
Numinus Wellness
0.04
0.00
0.00%
TSE:DR
Medical Facilities
16.49
1.64
11.05%
TSE:CALM
Revitalist Lifestyle & Wellness Ltd
0.02
0.00
0.00%
Premier Health of America Inc Corporate Events
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Premier Health Shareholders Back Board, Auditor and Stock Option Plan at AGM
Positive
Mar 26, 2026
Premier Health of America Inc. reported that all items presented to shareholders were approved at its annual general meeting held on March 26, 2026, including the reappointment of Raymond Chabot Grant Thornton LLP as auditor and the election of di...
Business Operations and StrategyFinancial Disclosures
Premier Health Narrows Focus to Travel Nurses as Revenue Slides in Q1 2026
Negative
Feb 26, 2026
Premier Health of America reported first-quarter 2026 revenues of $17.8 million, down sharply from $32.1 million a year earlier, with gross margin slipping to 15.28% and adjusted EBITDA essentially flat at $5,000. The company posted a net loss of ...
Business Operations and StrategyFinancial Disclosures
Premier Health of America Widens Loss as It Exits Per Diem Segment and Refocuses on Travel Nurses
Negative
Jan 27, 2026
Premier Health of America reported a sharp year-over-year decline in fiscal 2025 results, with annual revenues falling to $101.97 million from $158.19 million and adjusted EBITDA dropping to $1.67 million from $6.56 million, alongside a widened ne...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.